Raffles Medical BSL

SGD 0.835 -0.60% -0.01 Updated 16 Nov 2026, 10:04 SGT

Company profile

The business, the people and the ownership behind Raffles Medical.

Business overview

About the company

Raffles Medical Group provides integrated private healthcare services across Asia. Its offerings span primary, secondary and tertiary care, wellness and health insurance, delivered through hospitals and multidisciplinary clinics.

Annual Report 2025 ↗ Reviewed 2026-10-23 · Source dated 2026-04-01. PDF p. 4

Listed security

Company & listing

Full Company Name
RAFFLES MEDICAL GROUP LTD
Trading Currency
SGD
Website
www.rafflesmedicalgroup.com
Listing
Listed on 11 April 1997 on SGX Sesdaq 10 July 2000 on SGX Mainboard
ISIN Code
SG1CH4000003

Board & management

Leadership

Earlier original-report historical backfill remains incomplete.

Loo Choon Yong

Executive Chairman; Non-Independent Director

Board of Directors As reported at 2025-12-31

Chief Executive Officer (CEO)

CEO

First appointment: 16/05/1989; last re-election: 28/04/2023

Raffles Medical Group Board; first appointment and last re-election

Lew Yoong Keong Allen

Lead Independent Director

Board of Directors As reported at 2025-12-31

First appointment: 28/10/2020; last re-election: 26/04/2024

Raffles Medical Group Board; first appointment and last re-election

Png Cheong Boon

Independent Director

Board of Directors As reported at 2025-12-31

First appointment: 15/10/2018; last re-election: 25/04/2025

Raffles Medical Group Board; first appointment and last re-election

Tan Wern Yuen

Independent Director

Board of Directors As reported at 2025-12-31

First appointment: 01/07/2021; last re-election: 25/04/2025

Raffles Medical Group Board; first appointment and last re-election

Chong Chuan Neo

Independent Director

Board of Directors As reported at 2025-12-31

First appointment: 15/10/2021; last re-election: 25/04/2025

Raffles Medical Group Board; first appointment and last re-election

Lim Sim Seng

Independent Director

Board of Directors As reported at 2025-12-31

Announced change after FY2025 (AGM2026): retiring after the conclusion of AGM 2026; Independent Director of the RMG Board since August 2023; member of the Audit & Risk Committee since April 2024

Board of Raffles Medical Group; future change announced in Chairman’s Message

First appointment: 01/08/2023; last re-election: 26/04/2024

Raffles Medical Group Board; first appointment and last re-election

Sung Jao Yiu

Independent Director

Board of Directors As reported at 2025-12-31

First appointment: 01/12/2021; last re-election: 25/04/2025

Raffles Medical Group Board; first appointment and last re-election

Tan Soo Nan

Non-Executive and Non-Independent Director

Board of Directors As reported at 2025-12-31

Announced change after FY2025 (AGM2026): retires from the Board after the conclusion of the Annual General Meeting (AGM) 2026; Deputy Chairman of the RHI Board

Board of Raffles Medical Group; future change announced in Chairman’s Message

First appointment: 28/07/2000; last re-election: 28/04/2023

Raffles Medical Group Board; first appointment and last re-election

Olivier Lim Tse Ghow

Non-Executive and Non-Independent Director

Board of Directors As reported at 2025-12-31

First appointment: 01/10/2014; last re-election: 28/04/2023

Raffles Medical Group Board; first appointment and last re-election

Sarah Lu Qinghui

Executive and Non-Independent Director

Board of Directors As reported at 2025-12-31

First appointment: 20/02/2018; last re-election: 26/04/2024

Raffles Medical Group Board; first appointment and last re-election

Lu Liangjian David

Non-Executive and Non-Independent Director

Board of Directors As reported at 2025-12-31

First appointment: 01/08/2023; last re-election: 26/04/2024

Raffles Medical Group Board; first appointment and last re-election

Roles listed in Annual Report 2025; current appointments are not independently verified.

Holdings

Ownership

Earlier original-report historical backfill remains incomplete.

Dr Loo Choon Yong

Direct: 251,635,323 shares (13.67%); deemed: 783,835,081 shares (42.60%); total: 1,035,470,404 shares (56.27%).

As recorded in the register of substantial shareholders; direct, deemed and total interests As reported at 2026-03-16

Raffles Medical Holdings Pte Ltd

Direct: 719,394,504 shares (39.09%); deemed: - shares (-); total: 719,394,504 shares (39.09%).

As recorded in the register of substantial shareholders; direct, deemed and total interests As reported at 2026-03-16

Global Alpha Capital Management Ltd

Direct: - shares (-); deemed: 110,218,022 shares (5.99%); total: 110,218,022 shares (5.99%).

As recorded in the register of substantial shareholders; direct, deemed and total interests As reported at 2026-03-16

Raffles Medical Holdings Pte Ltd

692,280,209 shares; 37.62%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Loo Choon Yong

251,635,323 shares; 13.67%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

DBS Nominees (Private) Limited

136,012,412 shares; 7.39%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Citibank Nominees Singapore Pte Ltd

118,507,286 shares; 6.44%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Raffles Nominees (Pte) Limited

84,167,625 shares; 4.57%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

S & D Holdings Pte Ltd

62,755,366 shares; 3.41%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

DBSN Services Pte Ltd

46,524,443 shares; 2.53%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

UOB Nominees (2006) Private Limited

27,114,295 shares; 1.47%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

HSBC (Singapore) Nominees Pte Ltd

20,555,477 shares; 1.12%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Tan Tiang Lee

16,228,192 shares; 0.88%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Asian Medical Foundation Ltd

14,443,321 shares; 0.78%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

United Overseas Bank Nominees (Private) Limited

11,882,192 shares; 0.65%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Phillip Securities Pte Ltd

10,184,796 shares; 0.55%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Yii Hee Seng

10,140,513 shares; 0.55%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

OCBC Nominees Singapore Private Limited

9,795,887 shares; 0.53%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

OCBC Securities Private Limited

8,727,126 shares; 0.47%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Maybank Securities Pte Ltd

7,859,128 shares; 0.43%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

IFast Financial Pte Ltd

6,240,734 shares; 0.34%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

BPSS Nominees Singapore (Pte) Ltd

5,700,110 shares; 0.31%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Tan Soo Nan @ Tan Soo Nam

4,671,000 shares; 0.25%.

Top 20 shareholders listed in source; registration/depository status not stated As reported at 2026-03-16

Dr Loo Choon Yong

Held in name of director/spouse/infant children: beginning of year 251,520,534, end of year 251,520,534; other holdings deemed: beginning of year 782,149,870, end of year 782,149,870.

Company ordinary shares; Directors’ Statement Section 164 register; named holdings and other deemed holdings kept separate As reported at 2025-12-31

Mr Lew Yoong Keong Allen

Held in name of director/spouse/infant children: beginning of year 200,000, end of year 200,000; other holdings deemed: beginning of year –, end of year –.

Company ordinary shares; Directors’ Statement Section 164 register; named holdings and other deemed holdings kept separate As reported at 2025-12-31

Mr Tan Soo Nan

Held in name of director/spouse/infant children: beginning of year 4,671,000, end of year 4,671,000; other holdings deemed: beginning of year –, end of year –.

Company ordinary shares; Directors’ Statement Section 164 register; named holdings and other deemed holdings kept separate As reported at 2025-12-31

Mr Olivier Lim Tse Ghow

Held in name of director/spouse/infant children: beginning of year 526,016, end of year 776,016; other holdings deemed: beginning of year –, end of year –.

Company ordinary shares; Directors’ Statement Section 164 register; named holdings and other deemed holdings kept separate As reported at 2025-12-31

Dr Sarah Lu Qinghui

Held in name of director/spouse/infant children: beginning of year 309,816, end of year 309,816; other holdings deemed: beginning of year 62,755,366, end of year 62,755,366.

Company ordinary shares; Directors’ Statement Section 164 register; named holdings and other deemed holdings kept separate As reported at 2025-12-31

Dr Lu Liangjian David

Held in name of director/spouse/infant children: beginning of year –, end of year –; other holdings deemed: beginning of year 62,755,366, end of year 62,755,366.

Company ordinary shares; Directors’ Statement Section 164 register; named holdings and other deemed holdings kept separate As reported at 2025-12-31

Dr Loo Choon Yong

Raffles Medical Holdings Pte Ltd: held in name at beginning of year 112,500 and at end of year 112,500; other deemed holdings: – at beginning of year, – at end of year.

Immediate holding company ordinary shares; named holdings versus deemed holdings As reported at 2025-12-31

Total interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.

Group structure

Main operating subsidiaries

Earlier original-report historical backfill remains incomplete.

CompanyMarketOwnership interest
Raffles Hospital Pte LtdGroup; 2025 and 2024PDF p. 219 Singapore; Provision of general and specialised medical services and operation of a hospital; 2025: 100%; 2024: 100%
Raffles Diagnostica Pte LtdGroup; 2025 and 2024PDF p. 219 Singapore; Operation of medical laboratory and imaging centre; 2025: 100%; 2024: 100%
Raffles Medical Properties Pte Ltd and its subsidiaries:Group; 2025 and 2024PDF p. 219 Singapore; Property owner and investment holding; 2025: 100%; 2024: 100%
Raffles Hospital Properties Pte LtdGroup; 2025 and 2024PDF p. 219 Singapore; Property owner; 2025: 100%; 2024: 100%
MP Clementi Pte LtdGroup; 2025 and 2024PDF p. 219 Singapore; Investment holding; 2025: 100%; 2024: 100%
RM Network Pte LtdGroup; 2025 and 2024PDF p. 219 Singapore; Management consultancy services for healthcare organisations; 2025: 100%; 2024: 100%
Raffles Research Labs Pte LtdGroup; 2025 and 2024PDF p. 219 Singapore; Research & experimental development on Biotechnology, Life & Medical Science (dormant); 2025: 100%; 2024: 100%
Raffles Chinese Medicine Pte LtdGroup; 2025 and 2024PDF p. 219 Singapore; Provision of general medical services, acupuncture and acupressure; 2025: 100%; 2024: 100%
Raffles Japanese Clinic Pte Ltd and its subsidiaries:Group; 2025 and 2024PDF p. 219 Singapore; Operation of medical clinics, provision of medical services and investment holding; 2025: 87.5%; 2024: 87.5%
RJC Ltd and its subsidiaries:Group; 2025 and 2024PDF p. 219 Japan; Investment holding; 2025: 87.5%; 2024: 87.5%
RSM Ltd and its subsidiary:Group; 2025 and 2024PDF p. 219 Japan; Provision of medical support and consultancy services; 2025: 87.5%; 2024: 87.5%
Zui Wa Kai Medical CorporationGroup; 2025 and 2024PDF p. 219 Japan; Operation of medical clinics and provision of medical services; 2025: –; 2024: –
Raffles Health Pte LtdGroup; 2025 and 2024PDF p. 220 Singapore; Trading in pharmaceutical and nutraceutical products and diagnostic equipment; 2025: 100%; 2024: 100%
Aptitude [2003] Pte LtdGroup; 2025 and 2024PDF p. 220 Singapore; Provision of advisory and consultancy services and developing IT solutions; 2025: 100%; 2024: 100%
Raffles Healthcare Management (China) LimitedGroup; 2025 and 2024PDF p. 220 Hong Kong; Provision of hospital management and hospital management consultancy services; 2025: 100%; 2024: 100%
Raffles Medical International Pte Ltd and its subsidiaries:Group; 2025 and 2024PDF p. 220 Singapore; Investment holding; 2025: 100%; 2024: 100%
Raffles Medical Group (Hong Kong) Limited and its subsidiaries:Group; 2025 and 2024PDF p. 220 Hong Kong; Investment holding and provision of medical and dental services; 2025: 100%; 2024: 100%
Coors Consultants LimitedGroup; 2025 and 2024PDF p. 220 Hong Kong; Provision of consultancy services; 2025: 100%; 2024: 100%
Medical Properties LimitedGroup; 2025 and 2024PDF p. 220 Hong Kong; Investment holding, provision of medical services and hospital operation; 2025: 100%; 2024: 100%
Anzheng (Chongqing) Hospital Co Ltd and its subsidiaries:Group; 2025 and 2024PDF p. 220 China; Property owner; 2025: 100%; 2024: 100%
Raffles Health Institute (China) Co LtdGroup; 2025 and 2024PDF p. 220 China; Provision of training services; 2025: 100%; 2024: 100%
Raffles Hospital Chongqing Co Ltd (fka ShenAn (Chongqing) Hospital Co Ltd)Group; 2025 and 2024PDF p. 221 China; Hospital management and operations; 2025: 100%; 2024: 100%
Renguang Health Management (Shanghai) Co LtdGroup; 2025 and 2024PDF p. 221 China; Hospital management and operations; 2025: 100%; 2024: 100%
Raffles Hospital Shanghai Co LtdGroup; 2025 and 2024PDF p. 221 China; Hospital management and operations; 2025: 100%; 2024: 100%
Raffles International Hospital Hainan Co LtdGroup; 2025 and 2024PDF p. 221 China; Provision of medical services; 2025: 100%; 2024: 100%
Raffles Medical Services (HK) LimitedGroup; 2025 and 2024PDF p. 221 Hong Kong; Provision of medical services; 2025: 100%; 2024: 100%
Renguang Management Consultancy (Shanghai) Co LtdGroup; 2025 and 2024PDF p. 221 China; Management consultancy; 2025: 100%; 2024: 100%
Dalian Jin Pu New District Anshen ClinicGroup; 2025 and 2024PDF p. 221 China; Operation of medical clinics and provision of medical services; 2025: –; 2024: –
Nanjing Lai Ning Clinic and its subsidiary:Group; 2025 and 2024PDF p. 221 China; Operation of medical clinics and provision of medical services; 2025: –; 2024: –
Tianjin Lai Ning Clinic and its subsidiary:Group; 2025 and 2024PDF p. 221 China; Operation of medical clinics and provision of medical services; 2025: –; 2024: –
Tianjin LaiRui ClinicGroup; 2025 and 2024PDF p. 221 China; Operation of medical clinics and provision of medical services; 2025: –; 2024: –
Shanghai Ruihe Clinic Co Ltd and its subsidiary:Group; 2025 and 2024PDF p. 221 China; Operation of medical clinics and provision of medical services; 2025: –; 2024: –
Shenzhen ShenAn ClinicGroup; 2025 and 2024PDF p. 221 China; Operation of medical clinics and provision of medical services; 2025: –; 2024: –
Raffles Health Insurance Pte LtdGroup; 2025 and 2024PDF p. 222 Singapore; Provision of health and related insurance; 2025: 100%; 2024: 100%
PT Raffles Medika IndonesiaGroup; 2025 and 2024PDF p. 222 Indonesia; Provision of hospital and healthcare management and consultancy services; 2025: 100%; 2024: 100%
Raffles SurgiCentre Pte Ltd and its subsidiaries:Group; 2025 and 2024PDF p. 222 Singapore; Provision of general and specialised medical services, operation of a hospital and investment holding; 2025: 100%; 2024: 100%
International SOS (MC Holdings) Pte Ltd and its subsidiaries:Group; 2025 and 2024PDF p. 222 Singapore; Provision of the usage of trade name, trademark and administration, training, network services and marketing services to related companies, and investment holding; 2025: 80%; 2024: 80%
Raffles Hospital Beijing Co LtdGroup; 2025 and 2024PDF p. 222 China; Provides medical services through operation of medical clinics; 2025: 80%; 2024: 80%
Nanjing International (SOS) ClinicGroup; 2025 and 2024PDF p. 222 China; Provides medical services through operation of medical clinics; 2025: 80%; 2024: 80%
Tianjin International (SOS) ClinicGroup; 2025 and 2024PDF p. 222 China; Provides medical services through operation of medical clinics; 2025: 80%; 2024: 80%
Lifetime Health Limited Liability CompanyGroup; 2025 and 2024PDF p. 222 Vietnam; Provides medical examination and treatment through its international polyclinics and specialty clinics; 2025: 80%; 2024: 80%
AEA International SOS (Cambodia) LtdGroup; 2025 and 2024PDF p. 222 Cambodia; Provides medical services through operation of medical clinics; 2025: 80%; 2024: 80%
International SOS (HK) Limited and its subsidiary:Group; 2025 and 2024PDF p. 223 Hong Kong; Provision of medical emergency assistance services, the sale of medical kits and investment holding; 2025: 80%; 2024: 80%
Shenzhen International SOS ClinicGroup; 2025 and 2024PDF p. 223 China; Provision of clinical services; 2025: 80%; 2024: 80%
Raffles Medical China Pte Ltd and its subsidiaries:Group; 2025 and 2024PDF p. 223 Singapore; Investment holding and provision of medical services and hospital operation; 2025: 100%; 2024: 100%
PeopleSolve Pte LtdGroup; 2025 and 2024PDF p. 223 Singapore; Provision of employment agency and other health services; 2025: 100%; 2024: 100%
Shanghai Capital Pte Ltd and its subsidiary:Group; 2025 and 2024PDF p. 223 Singapore; Investment holding; 2025: 100%; 2024: 100%
Shanghai Qihua Hospital Co LtdGroup; 2025 and 2024PDF p. 223 China; Property owner; 2025: 100%; 2024: 70%
RMG Capital Pte Ltd and its subsidiary:Group; 2025 and 2024PDF p. 223 Singapore; Investment holding; 2025: 100%; 2024: 100%
Asian Healthcare Capital Management Pte LtdGroup; 2025 and 2024PDF p. 223 Singapore; Property owner; 2025: 100%; 2024: 100%
Nicoll Capital Pte Ltd and its subsidiary:Group; 2025 and 2024PDF p. 223 Singapore; Investment holding; 2025: 100%; 2024: 100%
Nicoll Consultancy Pte LtdGroup; 2025 and 2024PDF p. 223 Singapore; Provision of management consultancy services for healthcare organisations; 2025: 100%; 2024: 100%
Raffles Medical Systems Pte Ltd and its subsidiary:Group; 2025 and 2024PDF p. 224 Singapore; Investment holding; 2025: 100%; 2024: –
Raffles Corporate Solutions Pte LtdGroup; 2025 and 2024PDF p. 224 Singapore; Provision of actuarial, auxiliary services to insurance and pension funding industries; 2025: 100%; 2024: –
Scotts Capital Pte Ltd and its subsidiary:Group; 2025 and 2024PDF p. 224 Singapore; Investment holding; 2025: 100%; 2024: 100%
Scotts Consultancy Pte LtdGroup; 2025 and 2024PDF p. 224 Singapore; Provision of management consultancy services for healthcare organisations (dormant); 2025: 100%; 2024: 100%
Scotts Medical Services Co LtdGroup; 2025 and 2024PDF p. 224 Vietnam; Provides medical examination and treatment through its international polyclinics and specialty clinic; 2025: 100%; 2024: 100%
Raffles Management Solutions Pte LtdGroup; 2025 and 2024PDF p. 224 Singapore; Investment holding; 2025: 100%; 2024: –

Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.

Senior executives

Key management

Key management

ItemValuePeriod / scopeSource
Dr Loo Choon Yong Executive Chairman PDF p. 19
Dr Sarah Lu Managing Director responsible for all commercial matters of Singapore Healthcare; Executive Medical Director of Raffles Physicians PDF p. 19
Dr Chng Shih Kiat Executive Medical Director of Raffles Physicians PDF p. 20
Ms Woo Yeng Yeng Chief Financial Officer PDF p. 20
Mr Terence Foo Chief Technology Officer PDF p. 20
Mrs Kimmy Goh Group Financial Controller; Company Secretary PDF p. 21
Dr Kenneth Wu Managing Director of Singapore Healthcare PDF p. 21
Mr Phua Tien Beng Managing Director of Raffles China Healthcare PDF p. 22
Mr Ben Siah General Manager PDF p. 22
Dr Tan Hsiang Lung General Manager responsible for Raffles Hospital in Singapore PDF p. 22

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Shareholding statistics

Share capital & shareholders

Share capital

ItemValuePeriod / scopeSource
Number of issued and fully paid shares 1,840,160,875 (excluding treasury shares) Company, as at 16 March 2026 · As at 2026-03-16 PDF p. 229
Class of shares Ordinary shares Company · As at 2026-03-16 PDF p. 229
Voting rights One vote per ordinary share Company · As at 2026-03-16 PDF p. 229

Treasury shares

ItemValuePeriod / scopeSource
Number and percentage of treasury shares held 44,384,050 (2.412% of the total number of issued ordinary shares, excluding treasury shares) Company, as at 16 March 2026 · As at 2026-03-16 PDF p. 229
Number of subsidiary holdings Nil Company · As at 2026-03-16 PDF p. 229

Free float

ItemValuePeriod / scopeSource
Shareholdings held in hands of public approximately 37.39% of the issued ordinary shares of the Company are held by the public, and therefore, Rule 723 of the Listing Manual is complied with. Company · As at 2026-03-16 PDF p. 229

Shareholding distribution

ItemValuePeriod / scopeSource
1 - 99 Shareholders 1,241; 8.29%; shares 53,444; 0.00% Size of Shareholdings band; shares exclude treasury shares · As at 2026-03-16 PDF p. 229
100 - 1,000 Shareholders 1,793; 11.98%; shares 969,007; 0.05% Size of Shareholdings band; shares exclude treasury shares · As at 2026-03-16 PDF p. 229
1,001 - 10,000 Shareholders 7,190; 48.05%; shares 37,301,829; 2.03% Size of Shareholdings band; shares exclude treasury shares · As at 2026-03-16 PDF p. 229
10,001 - 1,000,000 Shareholders 4,692; 31.36%; shares 210,370,268; 11.43% Size of Shareholdings band; shares exclude treasury shares · As at 2026-03-16 PDF p. 229
1,000,001 and above Shareholders 47; 0.32%; shares 1,591,466,327; 86.49% Size of Shareholdings band; shares exclude treasury shares · As at 2026-03-16 PDF p. 229

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Related parties, people & properties

Other disclosures

Related party transactions

ItemValuePeriod / scopeSource
Doctor World Pte Ltd $2,916,588 Aggregate value of all IPTs during FY2025 (excluding transactions less than $100,000 and under shareholders' mandate); mandate column: Nil PDF p. 112

Director remuneration

ItemValuePeriod / scopeSource
$500,000 and above 2 number of directors Number of directors, 2025 (2024: 2) PDF p. 98
$250,000 and below $500,000 - number of directors Number of directors, 2025 (2024: 1) PDF p. 98
Below $250,000 9 number of directors Number of directors, 2025 (2024: 9) PDF p. 98
Dr Loo Choon Yong 7,832,373 dollars FY2025 total compensation, Executive Chairman PDF p. 98
Dr Sarah Lu Qinghui 611,155 dollars FY2025 total compensation PDF p. 98

Employees

ItemValuePeriod / scopeSource
Permanent employees 2,965 employees Group, 2025 (2024: 2,989) PDF p. 52

Properties

ItemValuePeriod / scopeSource
A hospital building, located at 585 North Bridge 99 years commencing Group; tenure 99 years commencing from 01/03/1979; carrying amount $157,974k (2024: $162,195k); GFA 28,887.1 sq m PDF p. 165
A building, located at 25 Tannery Lane, Singapore Freehold Group; GFA 3,295.5 sq m; carrying amount $19,068k (2024: $19,231k) PDF p. 165
A hospital building, located at No. 2, Huashan 40 years commencing Group; tenure 40 years commencing from 30/11/2017; GFA 105,690.6 sq m; carrying amount $110,317k (2024: $115,768k) PDF p. 165
A hospital building, located at No. 200 Yuanzhao 50 years commencing Group; tenure 50 years commencing from 31/10/2015; GFA 72,233.3 sq m; carrying amount $158,316k (2024: $164,689k) PDF p. 165

Extracted from Annual Report 2025 and checked against the cited pages; see the original report for full context.

Source: Annual Report 2025 ↗

Corporate information

Registration & contacts

Incorporated In
SINGAPORE
Incorporated On
16 May 1989
Telephone
65 63111111
Fax
65 63381318
Registered Office
585 North Bridge Road #11-00
Raffles Hospital
Singapore 188770
Secretary
Yap Chew Fern
Wong Sien Ting
Registrar / Transfer Agent
BOARDROOM CORPORATE & ADVISORY SERVICES PTE. LTD.
Registrar Address
1 Harbourfront Avenue, Keppel Bay Tower, #14-07, Singapore 098632
Auditors
ERNST & YOUNG LLP
Other Stock Exchange Listings
*SINGAPORE EXCHANGE LTD.
Country
SINGAPORE
Security Type
stocks